Hudson Bay Capital Management LP Syndax Pharmaceuticals Inc Transaction History
Hudson Bay Capital Management LP
- $25.7 Billion
- Q2 2025
A detailed history of Hudson Bay Capital Management LP transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 443,300 shares of SNDX stock, worth $5.94 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
443,300
Previous 443,300
-0.0%
Holding current value
$5.94 Million
Previous $4.15 Million
-0.0%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding SNDX
# of Institutions
252Shares Held
100MCall Options Held
1.28MPut Options Held
1.29M-
Kynam Capital Management, LP Princeton, NJ8.52MShares$114 Million9.53% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$106 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY5.8MShares$77.6 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.03MShares$67.4 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.07MShares$54.4 Million3.84% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $757M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...